Jo Lowe

Ketamine augmentation of electroconvulsive therapy to improve neuropsychological and clinical outcomes in depression (Ketamine-ECT): a multicentre, double-blind, randomised, parallel-group, superiority trial

Ian Anderson, Andrew M. Blamire, Tim Branton et al. · The Lancet Psychiatry · 2017 · 106 citations · Full text

Medicine, Pharmacotherapy, Psychiatry +16

International Map of Axial Spondyloarthritis (IMAS): results from the perspective of 5557 patients from 27 countries around the globe

Marco Garrido‐Cumbrera, Denis Poddubnyy, Fernando Sommerfleck et al. · RMD Open · 2024 · 20 citations · Full text

Medicine, Internal Medicine, General Internal Medicine +9

Study protocol for the randomised controlled trial: Ketamine augmentation of ECT to improve outcomes in depression (Ketamine-ECT study)

Liam Trevithick, R. Hamish McAllister‐Williams, Andrew M. Blamire et al. · BMC Psychiatry · 2015 · 17 citations · Full text

Medicine, Pharmacology, Psychiatry +17

Factors Associated with Poor Mental Health in Patients with Axial Spondyloarthritis: Results from the International Map of Axial Spondyloarthritis (IMAS)

Marco Garrido‐Cumbrera, Victoria Navarro‐Compán, Denis Poddubnyy et al. · RMD Open · 2024 · 16 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +17

Randomised controlled trial of ketamine augmentation of electroconvulsive therapy to improve neuropsychological and clinical outcomes in depression (Ketamine-ECT study)

Ian Anderson, Andrew M. Blamire, Tim Branton et al. · Efficacy and Mechanism Evaluation · 2017 · 15 citations · Full text

Medicine, Pharmacotherapy, Psychiatry +17